10-Q/A Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q2 2012

Filing Information

Form Type	10-Q/A
Accession Number	`0001144204-12-047370`
Period End Date	20120630
Filing Date	20120821
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	enzn-20120630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 108 Cash Flow Statement 54

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Property and equipment, net of accumulated depreciation.	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$43.14M	USD	Point-in-time
Property and equipment, net of accumulated depreciation.	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$40.57M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$59.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$317.87M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$397.53M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$58.19M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$69.70M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.75M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.06M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$165.26M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$132.20M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $43,136 at June 30, 2012 and $40,573 at December 31, 2011	`PropertyPlantAndEquipmentNet`	$14.24M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $43,136 at June 30, 2012 and $40,573 at December 31, 2011	`PropertyPlantAndEquipmentNet`	$16.80M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$160.78M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$170.45M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$156.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.29M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.55M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$367.00K	USD	Point-in-time
Total assets	`Assets`	$317.05M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.55M	shares	Point-in-time
Total assets	`Assets`	$343.21M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.29M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$616.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$8.43M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$13.69M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$115.85M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$124.89M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.26M	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	-	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	$129.50M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$640.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.26M	USD	Point-in-time
Total liabilities	`Liabilities`	$146.03M	USD	Point-in-time
Total liabilities	`Liabilities`	$125.53M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 47,545,103 shares at June 30, 2012 and 48,292,702 shares at December 31, 2011	`CommonStockValue`	$483.00K	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 47,545,103 shares at June 30, 2012 and 48,292,702 shares at December 31, 2011	`CommonStockValue`	$475.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$341.76M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$337.41M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$3.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$502.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-146.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-145.06M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$191.52M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$197.18M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$317.05M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$343.21M	USD	Point-in-time

Income Statement 108 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$20.09M	USD	2 Qtrs
Royalties	`RoyaltyRevenue`	$9.77M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$9.17M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$20.93M	USD	2 Qtrs
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	-	USD	1 Quarter
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	-	USD	1 Quarter
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	-	USD	2 Qtrs
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	$5.00M	USD	2 Qtrs
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$33.00K	USD	1 Quarter
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$231.00K	USD	1 Quarter
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$136.00K	USD	2 Qtrs
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$1.32M	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$362.00K	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$196.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$604.00K	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$427.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$10.23M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$20.83M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$27.62M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$9.60M	USD	1 Quarter
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$12.59M	USD	2 Qtrs
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$10.06M	USD	1 Quarter
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$5.67M	USD	1 Quarter
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$20.61M	USD	2 Qtrs
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$831.00K	USD	2 Qtrs
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$113.00K	USD	2 Qtrs
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$28.00K	USD	1 Quarter
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$184.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$9.71M	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$4.36M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$8.03M	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$4.63M	USD	1 Quarter
General and administrative - contracted services	`GeneralAndAdministrativeExpenseContractedServices`	-	USD	1 Quarter
General and administrative - contracted services	`GeneralAndAdministrativeExpenseContractedServices`	-	USD	2 Qtrs
General and administrative - contracted services	`GeneralAndAdministrativeExpenseContractedServices`	$112.00K	USD	2 Qtrs
General and administrative - contracted services	`GeneralAndAdministrativeExpenseContractedServices`	$54.00K	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$-70.00K	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$1.03M	USD	2 Qtrs
Restructuring charges	`RestructuringCharges`	$-107.00K	USD	2 Qtrs
Restructuring charges	`RestructuringCharges`	$674.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$9.99M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$20.63M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$15.60M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$32.30M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-4.68M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-6.00M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$206.00K	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$242.00K	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$1.00M	USD	2 Qtrs
Investment income, net	`InvestmentIncomeNet`	$386.00K	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$845.00K	USD	2 Qtrs
Investment income, net	`InvestmentIncomeNet`	$523.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.48M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.78M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.36M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.96M	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$159.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$31.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$-193.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$-97.00K	USD	1 Quarter
Total other expense	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-1.96M	USD	2 Qtrs
Total other expense	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-938.00K	USD	1 Quarter
Total other expense	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-1.97M	USD	2 Qtrs
Total other expense	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-1.06M	USD	1 Quarter
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.77M	USD	2 Qtrs
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.63M	USD	2 Qtrs
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-696.00K	USD	1 Quarter
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.06M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$33.00K	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$33.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$5.00K	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$5.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.80M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-729.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.64M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.12	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.04	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.04	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.12	USD	2 Qtrs
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	53.05M	shares	1 Quarter
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	55.37M	shares	2 Qtrs
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.23M	shares	2 Qtrs
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.18M	shares	1 Quarter
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	53.05M	shares	1 Quarter
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.18M	shares	1 Quarter
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.23M	shares	2 Qtrs
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.37M	shares	2 Qtrs
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-57.00K	USD	1 Quarter
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$480.00K	USD	2 Qtrs
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-278.00K	USD	2 Qtrs
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-153.00K	USD	1 Quarter
Reclassification adjustment for realized losses (gains) on sales included in net loss	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$19.00K	USD	2 Qtrs
Reclassification adjustment for realized losses (gains) on sales included in net loss	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-16.00K	USD	1 Quarter
Reclassification adjustment for realized losses (gains) on sales included in net loss	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-58.00K	USD	1 Quarter
Reclassification adjustment for realized losses (gains) on sales included in net loss	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-80.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-358.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-73.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-211.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$499.00K	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.30M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-7.28M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-802.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-7.00M	USD	2 Qtrs

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-7.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.80M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-729.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.64M	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$2.56M	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$2.57M	USD	2 Qtrs
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$309.00K	USD	2 Qtrs
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$269.00K	USD	2 Qtrs
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$982.00K	USD	2 Qtrs
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$500.00K	USD	1 Quarter
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$700.00K	USD	1 Quarter
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$1.97M	USD	2 Qtrs
Losses (gains) on sales of marketable securities	`MarketableSecuritiesGainLoss`	$-80.00K	USD	2 Qtrs
Losses (gains) on sales of marketable securities	`MarketableSecuritiesGainLoss`	$19.00K	USD	2 Qtrs
Loss on early retirement of notes payable	`GainsLossesOnExtinguishmentOfDebt`	$212.00K	USD	2 Qtrs
Loss on early retirement of notes payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Other	`OtherNoncashIncomeExpense`	$1.56M	USD	2 Qtrs
Other	`OtherNoncashIncomeExpense`	$664.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$-7.25M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$-3.73M	USD	2 Qtrs
Net cash used in by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.40M	USD	2 Qtrs
Net cash used in by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.99M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$530.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.00K	USD	2 Qtrs
Proceeds from sales of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$4.00K	USD	2 Qtrs
Proceeds from sales of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$83.28M	USD	2 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$18.04M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$759.00K	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$105.54M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-22.27M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$16.76M	USD	2 Qtrs
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$5.32M	USD	2 Qtrs
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$96.05M	USD	2 Qtrs
Repurchases of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$-13.86M	USD	2 Qtrs
Repurchases of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	-	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$62.00K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$5.56M	USD	2 Qtrs
Withholding taxes - stock-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$76.00K	USD	2 Qtrs
Withholding taxes - stock-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$894.00K	USD	2 Qtrs
Redemptions from employee stock purchase plan, net	`ProceedsFromStockPlans`	$-42.00K	USD	2 Qtrs
Redemptions from employee stock purchase plan, net	`ProceedsFromStockPlans`	$-21.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-91.43M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-19.21M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-44.88M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-79.66M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$59.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$317.87M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$397.53M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$59.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$317.87M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$397.53M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.